DK1146117T3 - En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus - Google Patents

En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus

Info

Publication number
DK1146117T3
DK1146117T3 DK00201326T DK00201326T DK1146117T3 DK 1146117 T3 DK1146117 T3 DK 1146117T3 DK 00201326 T DK00201326 T DK 00201326T DK 00201326 T DK00201326 T DK 00201326T DK 1146117 T3 DK1146117 T3 DK 1146117T3
Authority
DK
Denmark
Prior art keywords
preparing
treatment
diabetes mellitus
matures
mature
Prior art date
Application number
DK00201326T
Other languages
English (en)
Inventor
Daniel Pipeleers
Original Assignee
Beta Cell N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beta Cell N V filed Critical Beta Cell N V
Application granted granted Critical
Publication of DK1146117T3 publication Critical patent/DK1146117T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00201326T 2000-04-12 2000-04-12 En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus DK1146117T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201326A EP1146117B1 (en) 2000-04-12 2000-04-12 A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus
CA2363971A CA2363971C (en) 2000-04-12 2001-11-26 A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
DK1146117T3 true DK1146117T3 (da) 2008-05-26

Family

ID=32070512

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00201326T DK1146117T3 (da) 2000-04-12 2000-04-12 En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus

Country Status (8)

Country Link
US (1) US6686197B2 (da)
EP (1) EP1146117B1 (da)
AT (1) ATE384781T1 (da)
CA (1) CA2363971C (da)
DE (1) DE60037876T2 (da)
DK (1) DK1146117T3 (da)
ES (1) ES2299417T3 (da)
PT (1) PT1146117E (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2465950A1 (en) * 2001-11-09 2003-05-15 Artecel Sciences, Inc. Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
US20040005301A1 (en) * 2002-02-12 2004-01-08 Goldman Steven A. Identification and high-yield isolation of human pancreatic islet progenitor and stem cells
EP1636348B1 (en) 2003-06-20 2009-07-29 Vrije Universiteit Brussel VUB Method of generating islet beta-cells from exocrine pancreatic cells
SG193615A1 (en) 2011-03-29 2013-11-29 Beta Cell Nv Method for encapsulated therapeutic products and uses thereof
WO2013060893A1 (en) * 2011-10-28 2013-05-02 Centre National De La Recherche Scientifique Process of diagnostic, prognostic and therapeutic monitoring of solid tumors
JP6420323B2 (ja) * 2013-09-19 2018-11-07 ベタ−セル エンフェーＢｅｔａ−Ｃｅｌｌ Ｎｖ 糖尿病の治療方法
AU2014326794B2 (en) 2013-09-24 2019-03-21 Giner, Inc. System for gas treatment of a cell implant
BR112019009712A2 (pt) 2016-11-15 2019-08-13 Giner Life Sciences Inc dispositivo de difusão gasosa percutânea adequado para uso com um implante subcutâneo
CN110831656A (zh) 2017-05-04 2020-02-21 吉纳生命科学公司 稳健的可植入气体递送装置和方法、系统以及包括该装置的装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5050612A (en) * 1989-09-12 1991-09-24 Matsumura Kenneth N Device for computer-assisted monitoring of the body
US5858973A (en) * 1994-02-23 1999-01-12 The General Hospital Corporation Transcription factor and uses therefor
US6110743A (en) * 1995-02-10 2000-08-29 The Regents Of The University Of California Development and use of human pancreatic cell lines

Also Published As

Publication number Publication date
EP1146117B1 (en) 2008-01-23
DE60037876D1 (de) 2008-03-13
US20020177228A1 (en) 2002-11-28
US6686197B2 (en) 2004-02-03
ATE384781T1 (de) 2008-02-15
DE60037876T2 (de) 2009-01-29
ES2299417T3 (es) 2008-06-01
CA2363971C (en) 2011-10-11
PT1146117E (pt) 2008-05-06
CA2363971A1 (en) 2003-05-26
EP1146117A1 (en) 2001-10-17

Similar Documents

Publication Publication Date Title
WO2002040630A3 (en) Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
BR0311362A (pt) métodos, composições e fatores de crescimento e de diferenciação para produzir células produtoras de insulina
AU8212301A (en) Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells
NO964342L (no) Fremgangsmåter for behandling av sykdom under anvendelse av Sertoli-celler og allografter eller zenografter
ATE367833T1 (de) IN-VITRO-VERFAHREN ZUM HERSTELLEN EINER HOMOLOGEN ßGESTENTETENß TISSUE ENGINEERTEN HERZKLAPPE
NZ592159A (en) Means and methods for influencing the stability of antibody producing cells
AU2001282123A1 (en) Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells
DK1165791T3 (da) Humant cytokin som zalpha-receptor-ligand og anvendelse deraf
WO2000031237A3 (en) Method of cloning porcine animals
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
DK1146117T3 (da) En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus
EP1759536A4 (en) IN VITRO TECHNIQUES FOR USE WITH STEM CELLS
WO2005121369A3 (en) Rna-containing microvesicles and methods therefor
WO2007035363A3 (en) Compositions and methods for the augmentation and repair of defects in tissue
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
DK0970701T3 (da) Pellets afledt fra keratinocytter til anvendelse som sårhelingsstoffer
ATE195555T1 (de) Verfahren zur herstellung transformierter zellen
NO20053357L (no) Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse.
WO2006034319A3 (en) Porcine reproductive and respiratory syndrome isolates and methods of use
WO2002010337A3 (en) Method of cloning porcine animals
WO2005030939A3 (en) Method and composition for regulating expansion of stem cells
WO2002043779A3 (en) Use of acacia gum (arabic gum) to isolate and preserve biological material
DE602006012425D1 (de) Verfahren zur herstellung einer voll entwickelten natürlichen killerzelle
IL145674A0 (en) USE OF ERbB RECEPTOR LIGANDS IN TREATING DIABETES
WO2005054447A3 (en) Müller stem cells